Synthetic Anabolic-Androgenic Steroids: A Plea for Controlled Substance Status

References

• Newerla GH: The history of the discovery and isolation of the male hormone. N Engl J Med 1943; 228(2): 39–47
   Google Scholar
• Taylor WN: Anabolic Steroids and the Athlete. Jefferson, NC, McFarland & Company, 1982
   Google Scholar
• Duda M: Do anabolic steroids pose an ethical dilemma for US physicians? Phys Sportsmed 1986; 14(November): 173–175
   PubMedGoogle Scholar
• Cowart V: Steroids in sports: After four decades, time to return these genies to bottle? Medical news & perspectives. JAMA 1987; 257(Jan 23): 421–427
   PubMed Web of Science ®Google Scholar
• Taylor WN: Hormonal Manipulation: A New Era of Monstrous Athletes. Jefferson, NC, McFarland & Company, 1985
   Google Scholar
• Nightingale SL: Illegal marketing of anabolic steroids to enhance performance charged, letter. JAMA 1986; 256(Oct 10): 1851
   Google Scholar
• Physician's Desk Reference. Oradell, NJ, Medical Economics Co Inc, 1986, p 1935
   Google Scholar
• Taylor WN: Are anabolic steroids for the long distance runner?, letter. Ann Sports Med 1984; 2(1): 51–52
   Google Scholar
• Taylor WN: Effects and actions of human growth hormone. Presented at symposium on drugs in sports, American College of Sports Medicine annual meeting, San Diego, May 24, 1984
   Google Scholar
• Strauss RH, Wright JE, Finerman GA: Anabolic steroid use and health status among forty-two weight-trained male athletes. Med Sci Sports Exerc 1982; 14(February): 119
   Google Scholar
• Lamb DR: Anabolic steroids in athletics: how well do they work and how dangerous are they? Am J Sports Med 1984; 12(January-February): 31–38
   PubMed Web of Science ®Google Scholar
• Strauss RH, Liggett MT, Lanese RR: Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA 1985; 253(May 17): 2871–2873
   PubMed Web of Science ®Google Scholar
• Taylor WN, Black AB: Pervasive anabolic steroid use among health club athletes. Ann Sports Med, to be published
   Google Scholar
• Wright JE: Anabolic steroids and athletes. Exerc Sport Sci Rev 1980; 8: 149–202
   PubMedGoogle Scholar
• Hill JA, Suker JR, Sachs K, et al: The athletic polydrug abuse phenomenon. A case study. Am J Sports Med 1983; 11 (July-August): 269–271
   PubMed Web of Science ®Google Scholar
• Alen M, Hakkinen K, Komi PV: Changes in neuromuscular performance and muscle fiber characteristics of elite power athletes self-administering androgenic and anabolic steroids. Acta Physiol Scand 1984; 122(December): 535–544
   PubMedGoogle Scholar
• Alen M, Hakkinen K: Physical health and fitness of an elite bodybuilder during 1 year of self-administration of testosterone and anabolic steroids: A case study. Int J Sports Med 1985; 6(February): 24–29
   PubMedGoogle Scholar
• Forbes GB: The effect of anabolic steroids on lean body mass: the dose response curve. Metabolism 1985; 34(June): 571–573
   PubMedGoogle Scholar
• Strauss RH, Wright JE, Finerman GA, et al: Side effects of anabolic steroids in weight-trained men. Phys Sportsmed 1983; 11(December): 86–98
   Google Scholar
• Costili DL, Pearson DR, Fink WJ: Anabolic steroid use among athletes: changes in HDL-C levels. Phys Sportsmed 1984; 12(June): 112–117
   Google Scholar
• Peterson FE, Fahey TD: HDL-C in five elite athletes using anabolic-androgenic steroids. Phys Sportsmed 1984; 12(June): 120–130
   Google Scholar
• Cohen JC, Faber WM, Benade AJ, et al: Altered serum lipoprotein profiles in male and female power lifters ingesting anabolic steroids. Phys Sportsmed 1986; 14(June): 131–136
   PubMed Web of Science ®Google Scholar
• Taylor WN: Growth hormone: preventing athletic abuse. Technology Rev 1985; 88(7): 14–15
   Web of Science ®Google Scholar
• Taylor WN: Human growth hormone: a controlled substance, proposal. Testimony to AMA House of Delegates Reference Committee E, June 16, 1986, Chicago
   Google Scholar
• Taylor WN: Synthetic hGH should be classified as a controlled substance to prevent abuse. Genetic Eng News 1986; 6(4): 4
   Google Scholar
• Burkett LN, Falduto MT: Steroid use by athletes in a metropolitan area. Phys Sportsmed 1984; 12(August): 69–74
   Google Scholar
• Woolley BH, Barnett DW: The use and misuse of drugs by athletes. Houston Med J 1986; 2: 29–35
   Google Scholar
• Ryan AJ: Anabolic steroids are fool's gold. R: d Proc 1981; 40(October): 2682–2688
   Google Scholar
• Taken from court exhibits, US v James Bradshaw; Case No. 86–6113, US District Court, Southern District of Florida, October 1986
   Google Scholar
• Moxley JH: Drug Abuse in Athletes: Anabolic Steroids and Human Growth Hormone. AMA, Report of the Council on Scientific Affairs, Resolution 57, A-86, December 1986
   Google Scholar
• Stedman's Medical Dictionary, ed 23. Baltimore, Williams & Wilkins, 1977, p 21
   Google Scholar
• Rusicka L, Wettstein A, Kaegi H: Sexualhormone VIII Darstellung von Testosterone unter Anwedung gemischter ester. Helv Chim Acts 1935; 18: 1478
   Google Scholar
• Butenandt A, Hanisch F: Uber Testosterone, Umwandlund des Dchydro-androsterons in Androstendiol und Testosteron; ein Weg zur Darstellung des Testosterons aus Cholesterin. Ztschr f physiol Chem 1935; 237: 89
   Google Scholar
• De Kruif P: The Male Hormone. New York City, Harcourt Brace Jovanovich Inc, 1945
   Google Scholar
• Greenblatt RB: Androgenic therapy in women. J Clin Endocrinol 1942; 2(November): 65–66
   Google Scholar
• Salmon UJ, Geist SH: Effect of androgens upon libido in women. J Clin Endocrinol 1943; 3(April): 235–238
   Google Scholar
• Masters WH, Magallon DT: Androgen administration in the postmenopausal woman. J Clin Endocrinol 1950; 10 (March): 348–358
   Google Scholar
• Henneman PH, Wallach S: A review of the prolonged use of estrogens and androgens in postmenopausal and senile osteoporosis. Arch Int Med 1957; 100(November): 715–723
   Google Scholar
• Scott JA, Cumming EXT: The menopause. Curr Probl Obstet Gynecol Fertil 1985; 8(1): 41
   Google Scholar
• Chestnut CH, Baylink DJ, Nelp WB: Stanozolol therapy in postmenopausal osteoporosis: preliminary results. Clin Res 1979; 26(February): 363A
   Google Scholar
• Greenblatt RB, Barfield WE, Garner JF, et al: Evaluation of estrogen, androgen, estrogen-androgen combination, and a placebo in the treatment of menopause. J Clin Endocrinol 1950; 10(December): 1547–1558
   Google Scholar
• Bancroft J, Sanders D, Davidson D, et al: Mood, sexuality, hormones and the menstrual cycle. III. Sexuality and the role of androgens. Psychosom Med 1983; 45(6): 509–516
   PubMed Web of Science ®Google Scholar
• Kwan M, Greenleaf WJ, Mann J, et al: The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metab 1983; 57(September): 557–562
   PubMedGoogle Scholar
• Bancroft J, Skakkebaek N: Androgens and human sexual behavior, in CIBA Foundation Symposium 62. Amsterdam, Excerpta Medica, 1978, p 209
   Google Scholar
• Nankin HR, Lin T, Osterman J: Chronic testosterone cypionate therapy in men with secondary impotence. Fertil Steril 1986; 46(August): 300–307
   PubMedGoogle Scholar
• Udry JR, Billy JO, Morris NM, et al: Serum androgenic hormones motivate sexual behavior in adolescent boys. Fertil Steril 1985; 43(January): 90–94
   PubMedGoogle Scholar
• Freed DL, Banks AJ, Longson D, et al: Anabolic steroids in athletics: Crossover double-blind trial on wcightlifters. Br Med J 1975; 2(May 31): 471–473
   PubMed Web of Science ®Google Scholar
• Nagelberg SB, Laue L, Loriaux DL, et al: Cerebrovascular accident associated with testosterone therapy in a 21-year-old hypogonadal man. N Engl J Med 1986; 314(Mar 6): 649–650
   PubMed Web of Science ®Google Scholar
• Miller NE, Hubert G, Hamilton JB: Mental and behavioral changes following male hormone treatment of adult castration, hypogonadism and psychic impotence. Proc Soc Exp Bio Med 1938; 38(July): 538–540
   Google Scholar
• Samuels LT, Henschel AF, Keys A: Influence of methyltestosterone on muscular work and creatine metabolism in normal young men. J Clin Endocrinol 1942; 2(November): 649–654
   Google Scholar
• Sherwin BB, Gelfand MM: Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985; 151 (Jan 15): 153–160
   PubMed Web of Science ®Google Scholar
• Glass SF: The advantages of combined estrogen-androgen therapy of the menopause. J Clin Endocrinol 1950; 10(December): 1616–1617
   Google Scholar
• Hervey GR: Are athletes wrong about anabolic steroids? Br J Sports Med 1975; 9(July): 74–77
   PubMedGoogle Scholar
• Lucking MT: Steroid hormones in sports. Special reference: sex hormones and their derivatives. Int J Sports Med 1982; 3(February): 65–67
   Google Scholar
• Wilson JD, Griffin JE: The use and misuse of androgens. Metabolism 1980; 29(December): 1278–1295
   PubMedGoogle Scholar
• Crist DM, Stackpole PJ, Peake GT: Effects of androgenic-anabolic steroids on neuromuscular power and body composition. J Appl Physiol 1983; 54(February): 366–370
   PubMedGoogle Scholar
• Lamb DR: Androgens and exercise. Med Sci Sports 1975; 7(Spring): 1–5
   PubMedGoogle Scholar
• Simonson E, Kerns WM, Enzer N: Effect of methyltestosterone treatment on muscular performance and the central nervous system of older men. J Clin Endocrinol 1944; 4: 549–554
   Google Scholar
• Ryan AJ: Athletics, in Kockakian CD (ed): Anabolic-Androgenic Steroids. Berlin, Springer-Verlag, 1976, pp 511–534, 723–725
   Google Scholar
• Package literature insert and promotional literature for Dianabol. Summit, NJ, Ciba-Geigy Pharmaceutical Division, 1961
   Google Scholar
• Package literature insert and promotional literature for Winstrol. Middleboro, MA, Winthrop Co Inc, 1965
   Google Scholar
• O'Shea JP: The effects of an anabolic steroid on dynamic strength levels of weight lifters. Nutr Rpts Inter 1971; 4(December): 363–370
   Google Scholar
• O'Shea JP, Winkler W: Biochemical and physical effects of an anabolic steroid in competitive swimmers and weight lifters. Nutr Rpts Inter 1970; 2(Deccmber): 351–362
   Google Scholar
• O'Shea JP: Biochemical evaluation of the effects of stanozolol on adrenal, liver and muscle function in man. Nutr Rpts Inter 1974; 10(Deccmbcr): 381–388
   Google Scholar
• Bowers RW, Reardon JP: Effects of methandrostenolone (Dianabol) on strength development and aerobic capacity. Med Sci Sports 1972; 4(Winter): 54
   Google Scholar
• Ward P: The effect of an anabolic steroid on strength and lean body mass. Med Sci Sports 1973; 5(Winter): 277–282
   PubMedGoogle Scholar
• Stanford BA, Moffatt R: Anabolic steroid: effectiveness as an ergogenic aid to experienced weight trainers. J Sports Med Phys Fitness 1974; 14(September): 191–197
   PubMedGoogle Scholar
• American College of Sports Medicine Position Statement on the Use and Abuse of Anabolic-Androgenic Steroids in Sports. Med Sci Sports 1977; 9(Winter): 11–13
   PubMedGoogle Scholar
• Haupt HA, Rovere GD: Anabolic steroids: a review of the literature. Am J Sports Med 1984; 12(6): 469–484
   PubMed Web of Science ®Google Scholar
• American College of Sports Medicine Position Stand on the Use of Anabolic-Androgenic Steroids in Sports, revised. Sports Med Bull 1984; 19(3): 13–18
   Google Scholar
• Hakkinen K, Alen M: Physiological performance, serum hormones, enzymes and lipids of an elite power athlete during training with and without androgens and during prolonged detraining. A case study. J Sports Med Phys Fitness 1986; 26(March): 92–100
   PubMedGoogle Scholar
• Allee WC, Collias NC, Lutherman CZ: Modification of the social order in flocks of hens by the injection of testosterone propionate. Physiol Zoology 1939; 12(4): 412–440
   Google Scholar
• Buoissou MF, Gaudioso V: Effect of early androgen treatment on subsequent social behavior in heifers. Horm Behav 1982; 16(June): 132–146
   PubMedGoogle Scholar
• Simon NG, Whalen RE, Tate MP: Induction of male-typical aggression by androgens but not by estrogens in adult female mice. Horm Behav 1985; 19(June): 204–212
   PubMedGoogle Scholar
• Van de Poll NE, de Jonge F, van Oyen HG, et al: Failure to find sex differences in testosterone activated aggression in two strains of rats. Horm Behav 1981; 15(March): 94–105
   PubMedGoogle Scholar
• Kurischko A, Oettel M: Androgen-dependent fighting behavior in male mice. Endokrinologie 1977; 70(September): 1–5
   PubMedGoogle Scholar
• Van de Poll NE, van Zanten S, de Jonge FH: Effects of testosterone, estrogen, and dihydrotestosterone upon aggressive and sexual behavior of female rats. Horm Behav 1986; 20(December): 418–431
   PubMedGoogle Scholar
• Bouissou MG: Androgens, aggressive behavior and social relationships in higher mammals. Horm Res 1983; 18(1–3): 43–61
   PubMedGoogle Scholar
• Zumpe D, Michael RP: Effects of testosterone on the behavior of male Cynomolgus monkeys (Macaca fascicularis). Horm Behav 1985; 19(September): 165–177
   Google Scholar
• Steklis HD, Brammer GL, Raleigh MJ, et al: Serum testosterone, male dominance, and aggression in captive groups of vervet monkeys (Cercopithecus aethiops sabaeus). Horm Behav 1985; 19(June): 154–163
   PubMedGoogle Scholar
• Sheridan PJ: Androgen receptors in the brain: what are we measuring? Endocr Rev 1983; 4(2): 171–178
   PubMed Web of Science ®Google Scholar
• Davidson JM: Neurohormonal bases for male sexual behavior. Int Rev Physiol 1977; 13(February): 225–254
   PubMedGoogle Scholar
• Vest SA, Howard JE: Clinical experiments with the use of male sex hormones. J Urol 1938; 40(January): 154
   Google Scholar
• Persky H, Smith KD, Basu GK: Relation of psychologic measures of aggression and hostility to testosterone production in man. Psychosom Med 1971; 33(May-June): 265–277
   PubMed Web of Science ®Google Scholar
• Kreuz LE, Rose RM: Assessment of aggressive behavior and plasma testosterone in a young criminal population. Psychosom Med 1972; 34(July-August): 321–332
   PubMed Web of Science ®Google Scholar
• Ehrenkrants JE, Bliss E, Sheard MH: Plasma testosterone: correlation with aggressive behavior and social dominance in man. Psychosom Med 1974; 36(November-December): 469–475
   PubMed Web of Science ®Google Scholar
• Doering CH, Brodie HK, Kraemer HC, et al: Negative effect and plasma testosterone: a longitudinal human study. Psychosom Med 1975; 37(November-December): 484–491
   PubMed Web of Science ®Google Scholar
• Rada RT, Laws DR, Kellner R: Plasma testosterone levels in the rapist. Psychosom Med. 1976; 38(July-August): 257–266
   PubMed Web of Science ®Google Scholar
• Rose RM: Testosterone, aggression and homosexuality: a review of the literature and implications for future research, in EJ Sachar (ed): Topics in Endocrinology. New York, Grune and Stratton, 1975, pp 83–103
   Google Scholar
• Olweus D, Mattsson A, Schalling D, et al: Testosterone, aggression, physical, and personality dimensions in normal adolescent males. Psychosom Med 1980; 42(March): 253–269
   PubMedGoogle Scholar
• Sherwin BB, Gelfand MM: Sex steroids and affect in the surgical menopause: a double-blind, cross-over study. Psycho- neuroendocrinology 1985; 10(3): 325–335
   PubMed Web of Science ®Google Scholar
• Taken from court exhibits, State of Maryland V Michael David Williams, April 1986
   Google Scholar
• Webb OL, Laskarzewski PM, Glueck CJ: Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism 1974; 33(November): 971–975
   Google Scholar
• Kantor MA, Bianchini A, Bernier D, et al: Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity. Med Sci Sports Exerc 1985; 17(August): 462–465
   PubMedGoogle Scholar
• Dorfman RI, Shipley RA: Androgens: Biochemistry, Physiology, and Clinical Significance. New York City, John Wiley & Sons, 1956
   Google Scholar
• Kruskemper HL: Anabolic Steroids. New York City, Academic Press, 1968
   Google Scholar
• Link K, Blizzard RM, Evans WS, et al: The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males. J Clin Endocrinol Metab 1986; 62(January): 159–164
   PubMedGoogle Scholar
• Fox M, Minot AS, Liddle GW: Oxandrolone: a potent anabolic steroid of novel chemical configuration. J Clin Endocrinol 1962; 22(September): 921–924
   Google Scholar
• Albanese AA, Lorenzc EJ, Orto LA, et al: Nutritional and metabolic effects of some newer steroids. III. Stanozolol. NY State J Med 1964; 64(April): 864–875
   PubMedGoogle Scholar
• Moore DC, Tattoni DS, Limbeck GA, et al: Studies of anabolic steroids: V. Effect of prolonged oxandrolone administration on growth in children and adolescents with uncomplicated short stature. Pediatrics 1976; 58(September): 412–422
   Google Scholar
• Marti-Henneberg C, Niirianen AK, Rappaport R: Oxandrolone treatment of constitutional short stature in boys during adolescence: effect on linear growth, bone age, pubic hair and testicular development. J Pediatr 1975; 86(May): 783–788
   PubMedGoogle Scholar
• Romshe CA, Sotos JF: The combined effect of growth hormone and oxandrolone in patients with growth hormone deficiency. J Pediatr 1980; 96(January): 127–131
   PubMedGoogle Scholar
• Couch M, Preston FE, Malia RG, et al: Changes in plasma osteocalcin concentrations following treatment with stanozolol. Clin Chim Acta 1986; 158 (July 15): 43–47
   PubMed Web of Science ®Google Scholar